What is BioInetlli?
BioIntelli operates at the intersection of big data and life science commercialization, providing sophisticated algorithmic solutions and comprehensive database management for the global research market. By synthesizing complex datasets, the company enables organizations to optimize their sales and marketing strategies across diverse sectors, including government agencies, private biopharma, academic research institutions, and venture capital firms. Its platform serves as an essential infrastructure tool for entities seeking to navigate the intricate landscape of life science funding and procurement, effectively bridging the gap between raw research data and actionable market intelligence.
How much funding has BioInetlli raised?
BioInetlli has raised a total of $142K across 2 funding rounds:
Debt
$20K
Debt
$122K
Debt (2021): $20K with participation from PPP
Debt (2025): $122K led by Northeast Bank
Key Investors in BioInetlli
Northeast Bank
A financial institution providing commercial banking and debt financing solutions to support corporate growth and operational scaling.
PPP
Public-Private Partnership
What's next for BioInetlli?
With this latest capital injection, BioIntelli is positioned to accelerate its market penetration and enhance its proprietary analytical engine. The strategic focus will likely shift toward scaling operations to meet the increasing demand for high-fidelity market insights within the biopharmaceutical sector. By leveraging its robust database, the company is well-equipped to refine its predictive modeling capabilities, thereby solidifying its competitive advantage. As it moves forward, BioIntelli will likely prioritize the expansion of its client base, targeting deeper integration into the procurement workflows of major research hospitals and global biotech conglomerates, ensuring its continued relevance as a foundational data partner in the life sciences industry.
See full BioInetlli company page
